Ambulatory Electrocardiography, commonly known as Holter Monitoring, serves as a non-invasive diagnostic tool to evaluate and track the heart's electrical activity over an extended timeframe, typically ranging from 24 to 48 hours. Named after its innovator, Dr. Norman J. Holter, this portable apparatus continuously records the heart's rhythm, offering a comprehensive overview of cardiac function during an individual's daily routine. Utilizing small electrodes affixed to the chest, the lightweight Holter monitor is discreetly worn on a belt or shoulder strap. This method of monitoring proves invaluable in identifying irregularities or anomalies that may escape notice during a brief clinical visit. Holter monitoring finds widespread application in diagnosing arrhythmias, assessing the efficacy of anti-arrhythmic medications, and investigating unexplained symptoms like palpitations, dizziness, or fainting episodes. The data amassed by the Holter monitor empowers healthcare practitioners to scrutinize the heart's electrical patterns, enabling informed decisions regarding suitable treatments or interventions.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation